A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...

After clicking Publish if Copilot We failed to publish your agent, Try publishing again later. Validation for the bot failed, ...

AI is flipping software development from execution to oversight. Here's how intent, validation and governance are replacing ...

The shift to multi-die assemblies is forcing changes in how chips are tested and inspected in order to achieve sufficient yield ramp or respond more quickly to yield excursions.

Explores LPCI, a new security vulnerability in agentic AI, its lifecycle, attack methods, and proposed defenses.

Leaks and Obstructions: Troubleshooting Common Problems Close to the Point of Sample Injection ...

Nuclear propulsion and power technologies could unlock new frontiers in missions to the Moon, Mars and beyond. NASA has reached an important milestone advancing nuclear propulsion that could benefit f ...

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...

Future expansion hinges on integrating digital connectivity with lab-quality sensitivity to solidify decentralized care. Domestic manufacturing initiatives and streamlined regulatory pathways will ...

Chicago, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The global lateral flow assay market was valued at USD 10.84 billion in 2025 and is estimated to reach valuation of USD 17.66 billion by 2035 at a CAGR of ...